Navigation Links
New Science Education Program Responds to President's Call to Help Young People Excel in Science
Date:5/3/2010

DEERFIELD, Ill., May 3 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced the launch of "Science WoRx," a program designed to help science teachers inspire the next generation of scientists. The program features a hands-on education and mentoring program, an online resource portal and online networking communities. In addition, Science WoRx is hosting a competition, "Make My LabWoRx," inviting science teachers to submit their favorite original lesson plans for a chance to win lab equipment for their school.

Astellas' announcement follows the launch of President Obama's "Educate to Innovate" campaign, which signals a significant unmet need to improve students' performance in science, technology, engineering and mathematics (STEM) subjects. Recent studies reveal that U.S. students are trailing behind other developed countries in science literacy. In the latest Programme for International Student Assessment (PISA) comparison study, U.S. students ranked 21st out of 30 in science literacy among developed countries.(1)  

In addition, according to the Lemelsen-MIT Invention Index, approximately one-third of teens indicate that they are discouraged from pursuing a career in STEM fields because they do not know anyone who works in these fields or understand what people in these fields do.(2)

"Science WoRx was developed to address the critical need for more resources in the classroom. The future Nobel Laureates in chemistry and medicine are sitting in our classrooms," said Seigo Kashii, president and CEO of Astellas Pharma US, Inc. "Our hope is that Science WoRx will provide teachers with the support they need to help prepare the world's pipeline of future scientists." '/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
4. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
5. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
6. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
7. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
8. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
9. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 More than ... the country will convene in Indianapolis ... (CADCA),s 2015 Mid-Year Training Institute . The week-long ... how to address one of our nation,s biggest public ... CADCA,s Mid-Year Training Institute is a one-of-a-kind intensive training ...
(Date:7/31/2015)... According to a new market research report " Sterilization ... Filtration, E-beam, Gamma), Services (Onsite & Offsite), Consumables (Indicators, Detergents, ... 2020", published by MarketsandMarkets, The Sterilization Equipment Market is expected ... CAGR of 7.6%.from 2015 to 2020. Browse ... and 37 F igures spread ...
(Date:7/31/2015)... WOODCLIFF LAKE, N.J. and SAN ... announced today that its parent company Eisai Co., Ltd. ... Haruo Naito , "Eisai") and Halozyme Therapeutics, Inc. ... and CEO: Dr. Helen Torley , "NASDAQ: HALO") ... eribulin mesylate (brand name: Halaven ® , "eribulin") in ...
Breaking Medicine Technology:Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6
... WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif., May ... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... evaluating Nexavar® (sorafenib) tablets in patients with locally ... a bevacizumab-containing regimen, which showed that Nexavar was ...
... WASHINGTON, May 18, 2011 Ten percent of cancer patients failed ... a new study published jointly today in the Journal of ... Managed Care ( AJMC ). The study was based on ... over a two-year period from 2007 to 2009. This study has ...
Cached Medicine Technology:Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 2Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 3Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 4Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 5Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 6Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 7Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 8New Study Finds That 10% of Cancer Patients Abandoned Oral Anti-Cancer Drugs 2New Study Finds That 10% of Cancer Patients Abandoned Oral Anti-Cancer Drugs 3New Study Finds That 10% of Cancer Patients Abandoned Oral Anti-Cancer Drugs 4
(Date:8/1/2015)... ... ... reTXT ” was featured on NewsWatch as part of its monthly AppWatch, which takes ... and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the app ... including ones already sent. , While text messaging has more features than it did ...
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, ... on the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. ... this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... its new store run by GoodThreads. The store can be accessed by visiting ... designs, many of which are customizable. The best part: whenever a product is ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... communicate. Rally Insurance Group, Inc. has re-branded their social media profiles to better ... personal way for consumers to communicate, find information, share insights and opinions. The ...
(Date:7/31/2015)... ... 2015 , ... According to an article published July 2 on ... reach a consensus on the steps that need to be taken to successfully complete ... percent consensus on a series of steps that each surgeon must complete for each ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
... announced today that 10 current and prospective Capella University students ... the field of mental health services. Half are pursuing online ... specializations in psychology and counseling. , ... ...
... way at Rush University Medical Center using a small, soft-patch device ... outerwear to close a common hole found in the heart ... strokes and transient ischemic attacks (TIAs) in adults. , ... involved in the trial and one of only 50 sites in ...
... just for newlyweds anymore. , They are also a way ... according to Kansas State University aging experts. , "By law ... residents some privacy," said Gayle Doll, who directs K-State,s Center ... for nursing home residents who want to engage in sexual ...
... of Americans suffering from the chronic inflammatory bowel condition ... due to innovative new surgeries, according to experts at ... of five Crohn,s patients will require some kind of ... advanced, often minimally invasive techniques are sparing precious bowel ...
... now face greater threat from other disease, study says , , ... about twice the risk of developing a non-AIDS cancer as ... Men with HIV were 2.3 times more likely, while women ... develop these other cancers, according to a meta-analysis expected to ...
... developed by Mitchell Sogin of the Marine Biological Laboratory ... completed the most precise survey to date of how ... treatment. , Sogin, director of the MBL,s Josephine Bay ... with David Relman and Les Dethlefsen of Stanford University, ...
Cached Medicine News:Health News: Capella University Announces $50,000 in Scholarships to Graduate Students in Mental Health Services : Ten students are awarded scholarships at online university 2Health News: Capella University Announces $50,000 in Scholarships to Graduate Students in Mental Health Services : Ten students are awarded scholarships at online university 3Health News: Capella University Announces $50,000 in Scholarships to Graduate Students in Mental Health Services : Ten students are awarded scholarships at online university 4Health News:Study investigates Gore-tex-type device to stop strokes and mini-strokes 2Health News:Study investigates Gore-tex-type device to stop strokes and mini-strokes 3Health News:K-State helps nursing home staff become comfortable with residents' sexual expression 2Health News:Crohn's disease surgeries make steady advances 2Health News:Crohn's disease surgeries make steady advances 3Health News:Non-AIDS Cancer Risk Higher for Those With HIV 2Health News:Antibiotics can cause pervasive, persistant changes to microbiota in human gut 2
... II) is the most potent pressure agent ... active peptide of the renin-angiotensin system (RAS). ... secreted primarily by the juxtaglomerular cells of ... decapeptide angiotensin I (Ang I) which is ...
Troponin I EIA Hypertension/ Cardiac Evaluation 025-BC-1105...
ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
... Insulin ELISA is a solid phase two-site ... the direct sandwich technique in which two ... determinants on the human insulin molecule. ... with peroxidase-conjugated anti-insulin antibodies and anti-insulin antibodies ...
Medicine Products: